Literature DB >> 11498256

Experimental autoimmune uveoretinitis in mice (Biozzi ABH and NOD) expressing the autoimmune-associated H-2A(g7) molecule: identification of a uveitogenic epitope.

D J Hankey1, J M Nickerson, L A Donoso, S L Lightman, D Baker.   

Abstract

To determine whether Biozzi ABH (H-2A(g7)) mice were susceptible to chronic experimental autoimmune uveoretinitis (EAU). Biozzi ABH were immunized with the two retinal antigens, interphotoreceptor retinoid binding protein (IRBP) and soluble antigen (S-Ag). Biozzi ABH mice were found to be susceptible to EAU induction with native bovine IRBP. Recombinant protein domains were used to identify IRBP domain 2 (EcR2) as the uveitogenic domain. Histopathological examination indicated that EcR2-induced disease was of a chronic, non-destructive nature in the Biozzi ABH. Using synthetic overlapping peptides corresponding to EcR2, a uveitogenic and immunogenic epitope was identified corresponding to human IRBP511-530. Non-obese diabetic (NOD) mice share the same MHC class II (H-2A(g7)) molecule as the Biozzi ABH, and were also found to be susceptible to EAU induction with EcR2. This study has identified a novel mouse model of EAU, whereby disease is of a chronic, non-destructive nature, which has potential to be used in immune manipulation and neuroprotection studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498256     DOI: 10.1016/s0165-5728(01)00341-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

1.  Identification of novel dendritic cell populations in normal mouse retina.

Authors:  Heping Xu; Rosemary Dawson; John V Forrester; Janet Liversidge
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

2.  Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model.

Authors:  David Baker; Erik Nutma; Helen O'Shea; Anne Cooke; Jacqueline M Orian; Sandra Amor
Journal:  Ann Clin Transl Neurol       Date:  2019-07-15       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.